Product Information
MEFENAMIC ACID 250 MG CAPSULE is a generic product labeled by Micro Labs Limited, priced at $0.9479 per EA under NDC 42571025830. Its NADAC has been published 474 times since Jan 4, 2017.
FDA first approved this application on Nov 19, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Micro Labs LimitedNDC
42571025830
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MEFENAMIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA090562FDA Approved
11/19/2010
TE Code
AB
On Market Since
11/19/2010
Pharmacological Classes
Price Statistics
The NADAC for MEFENAMIC ACID 250 MG CAPSULE has been published 474 times since Jan 4, 2017, and over the history we have for it it has declined 87.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9479 per EA |
|---|---|
| All-time high | $7.5923 (Jan 11, 2017) |
| All-time low | $0.9221 (Jul 22, 2026) |
| 52-week high | $1.0357 |
| 52-week low | $0.9221 |
| Median price | $1.8187 |
| Average price | $2.6991 |
| Largest weekly change | -40.1% (Jun 17, 2020) |
| Weeks tracked | 474 |
| Tracking since | Jan 4, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Mefenamic acid market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Micro Labs Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mefenamic acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEFENAMIC ACID 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEFENAMIC ACID 250 MG CAPSULE, manufactured by Micro Labs Limited, is $0.9479 per EA (NDC 42571025830), effective Sep 30, 2026.
How has the price of MEFENAMIC ACID 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEFENAMIC ACID 250 MG CAPSULE has declined 87.5%. It has been tracked across 474 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for MEFENAMIC ACID 250 MG CAPSULE?
Since Jan 4, 2017, the NADAC for MEFENAMIC ACID 250 MG CAPSULE has ranged from a low of $0.9221 (Jul 22, 2026) to a high of $7.5923 (Jan 11, 2017), with a median of $1.8187 per EA.
Are there cheaper alternatives to MEFENAMIC ACID 250 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of MEFENAMIC ACID 250 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MEFENAMIC ACID 250 MG CAPSULE?
MEFENAMIC ACID 250 MG CAPSULE (NDC 42571025830) is labeled by Micro Labs Limited, and CMS classifies it as a generic product.